A 'life-changing' new treatment for people living with sickle cell disease is to be made available on the NHS. Around 4,000 people living with the potentially fatal blood disorder could see their lives transformed by the drug Voxelotor. Hazel Attua, 33, has been taking the medication for nearly two years. The former finance worker said the chronic pain forced her to quit her career. She said: 'One of the most significant changes I've experienced is in my energy levels.
It was initially rejected for widespread NHS use but the National Institute for Health and Care Excellence has approved the drug in final draft guidance after a reduction in its price. John James, chief executive of the Sickle Cell Society, said: 'Today's approval by NICE marks a significant milestone in sickle cell care, addressing decades of limited access to disease-modifying treatments.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: LBCNews - 🏆 75. / 59 Read more »